Fingerprint
Dive into the research topics of 'Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically